Obstructive sleep apnea and endothelial function in school-aged nonobese children: Effect of adenotonsillectomy

Circulation

Volumn 116, Issue 20, 2007, Pages 2307-2314

  Gozal, David ^a   Kheirandish Gozal, Leila ^a   Serpero, Laura D ^a   Capdevila, Oscar Sans ^a   Dayyat, Ehab ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Endothelium; Hypoxia; Inflammation; Nitric oxide; Sleep

Indexed keywords

3 NITROTYROSINE; CD40 LIGAND; N(G),N(G) DIMETHYLARGININE;

ADENOTONSILLECTOMY; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ETHNICITY; FAMILY HISTORY; FEMALE; GENDER; HUMAN; HYPEREMIA; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

ADENOIDECTOMY; ANOXIA; ARGININE; BODY WEIGHT; CD40 LIGAND; CHILD; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPEREMIA; MALE; NITRIC OXIDE; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; TONSILLECTOMY; TYROSINE; VASCULITIS;

EID: 36049051681     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.696823     Document Type: Article

References (43)

1. Rosen CL, Larkin EK, Kirchner HL, Emancipator JL, Bivins SF, Surovec SA, Martin RJ, Redline S. Prevalence and risk factors for sleep disordered breathing in 8- to 11-year-old children: association with race and prematurity. J Pediatr. 2003;142:383-389.
2. Arens R, Marcus CL. Pathophysiology of upper airway obstruction: a developmental perspective. Sleep. 2004;27:997-1019.
3. Kheirandish L, Gozal D. Neurocognitive dysfunction in children with sleep disorders. Dev Sci. 2006;9:388-399.
4. Amin RS, Carroll JL, Jeffries JL, Grone C, Bean JA, Chini B, Bokulic R, Daniels SR. Twenty-four hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med. 2004;169:950-956.
5. Itzhaki S, Lavie L, Pillar G, Tal G, Lavie P. Endothelial dysfunction in obstructive sleep apnea measured by peripheral arterial tone response in the finger to reactive hyperemia. Sleep. 2005;28:594-600.
6. Otto ME, Svatikova A, Barretto RB, Santos S, Hoffmann M, Khandheria B, Somers V. Early morning attenuation of endothelial function in healthy humans. Circulation. 2004;109:2507-2510.
7. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004;169:348-353.
8. O'Brien LM, Gozal D. Autonomic dysfunction in children with sleep-disordered breathing. Sleep. 2005;28:747-752.
9. Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med 1998;157:1098-1103.
10. Enright PL, Goodwin JL, Sherrill DL, Quan JR, Quan SF; Tucson Children's Assessment of Sleep Apnea Study. Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and Hispanic children: the Tucson Children's Assessment of Sleep Apnea Study. Arch Pediatr Adolesc Med. 2003;157:901-904.
11. O'Brien LM, Serpero LD, Tauman R, Gozal D. Plasma adhesion molecules in children with sleep-disordered breathing. Chest. 2006;129:947-953.
12. Ohike Y, Kozaki K, Iijima K, Eto M, Kojima T, Ohga E, Santa T, Imai K, Hashimoto M, Yoshizumi M, Ouchi Y. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure: possible involvement of nitric oxide and asymmetric NG,NG-dimethylarginine. Circ J. 2005;69:221-226.
13. Boger RH, Bode-Boger SM, Szuba A, Tangphao O, Tsao PS, Chan JR, Blaschke TF, Cooke JP. Asymmetric dimethylarginine: a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 1998;98:1842-1847.
14. Böger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res. 2003;59:824-833.
15. Lu TM, Ding YA, Lin SJ, Lee WS, Tai HC. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J. 2003;24:1912-1919.
16. Lutgens E, Daemen M. CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med. 2002;12:27-32.
17. Mach F, Schonbeck U, Libby P. CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis. 1998;137(suppl):S89-S95.
18. Lobbes MB, Lutgens E, Heeneman S, Cleutjens KB, Kooi ME, van Engelshoven JM, Daemen MJ, Nelemans PJ. Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis. 2006;187:18-25.
19. Kobayashi K, Nishimura Y, Shimada T, Yoshimura S, Funada Y, Satouchi M, Yokoyama M. Effect of continuous positive airway pressure in soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Chest. 2006;129:632-637.
20. Hammer LD, Kraemer HC, Wilson DM, Ritter PL, Dornbusch SM. Standardized percentile curves of body mass index for children and adolescents. Am J Dis Child. 1991;145:259-263.
21. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555-576.
22. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring Systems for Sleep Stages of Human Subjects. Washington, DC: National Institutes of Health; 1968. Publication No. 204.
23. Montgomery-Downs HE, O'Brien LM, Gulliver TE, Gozal D. Polysomnographic characteristics in normal preschool and early school-age children. Pediatrics. 2006;117:741-753.
24. American Thoracic Society. Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med. 1996;153:866-878.
25. Aljadeff G, Gozal D, Schechtman VL, Burrell B, Harper RM, Ward SL. Heart rate variability in children with obstructive sleep apnea. Sleep. 1997;20:151-157.
26. Baharav A, Kotagal S, Rubin BK, Pratt J, Akselrod S. Autonomic cardiovascular control in children with obstructive sleep apnea. Clin Auton Res. 1999;9:345-351.
27. Amin RS, Kimball TR, Bean JA, Jeffries JL, Willging JP, Cotton RT, Witt SA, Glascock BJ, Daniels SR. Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med. 2002;165:1395-1399.
28. Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest. 2001;119:1085-1091.
29. Tauman R, Ivanenko A, O'Brien LM, Gozal D. Plasma C-reactive protein among children with sleep-disordered breathing. Pediatrics. 2004;113:e564-e569.
30. Tauman R, O'Brien LM, Gozal D. Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing. Sleep Breath. 2007;11:77-84.
31. Kheirandish-Gozal L, Sans Capdevila O, Tauman R, Gozal D. Plasma C-reactive protein in non-obese children with obstructive sleep apnea before and after adenotonsillectomy. J Clin Sleep Med. 2006;2:301-304.
32. Soukhova-O'Hare GK, Cheng JZ, Roberts AM, Gozal D. Postnatal intermittent hypoxia alters baroreflex function in adult rats. Am J Physiol Heart Circ Physiol. 2006;290:H1157-H1164.
33. Soukhova GK, Gozal D. Long-lasting plasticity of baroreceptor function following postnatal intermittent hypoxia in normotensive and hypertensive rats. Soc Neurosci Abs. 2004;Abstract 341.2.
34. Serpero LD, Kheirandish L, Sans Capevila O, Tauman R, Gozal D. Sleep fragmentation and circulating TNF-α levels in children with sleep disordered breathing. Proc Am Thor Soc. 2005;3:A555. Abstract.
35. Gozal D, Crabtree VM, Sans Capdevila O, Witcher LA, Kheirandish-Gozal L. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care Med. 2007;176:188-193.
36. Goldbart AD, Krishna J, Li RC, Serpero LD, Gozal D. Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest. 2006;130:143-148.
37. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med. 2005;172:364-370.
38. Gozal D, Kheirandish L. Oxidant stress and inflammation in the snoring child: confluent pathways to upper airway pathogenesis and end-organ morbidity. Sleep Med Rev. 2006;10:83-96.
39. Almendros I, Acerbi I, Puig F, Montserrat JM, Navajas D, Farre R. Upper-airway inflammation triggered by vibration in a rat model of snoring. Sleep. 2007;30:225-227.
40. Goldbart AD, Mager E, Veling MC, Goldman JL, Kheirandish-Gozal L, Serpero LD, Piedimonte G, Gozal D. Neurotrophins and tonsillar hypertrophy in children with obstructive sleep apnea. Pediatr Res. 2007;62:489-494.
41. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. J Pediatr. 2001;138:486-492.
42. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children. Pediatrics. 2001;107:E13.
43. Gozal D, Wang M, Pope DW Jr. Objective sleepiness measures in pediatric obstructive sleep apnea. Pediatrics. 2001;108:693-697.